Smith & Nephew plc reported $6.16B of revenue over the trailing twelve months, +6.1% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $6.16B (to FY2025). Net income: $625M, trailing twelve months to FY2025. Free cash flow: $599M, trailing twelve months to FY2018. Operating margin: 13%, trailing twelve months to FY2025.

SNNSmith & Nephew plc

Healthcare

$27.24-24% 1Y

$27.24

$26.4352 weeks$36.61

SNN as reported

Smith & Nephew plc reported $6.16B of revenue over the trailing twelve months, +6.1% on the year before. 11 reported series are charted on this page, each one as filed.

$6.16B

Revenue, trailing twelve months · to FY2025 · +6.1% against the twelve months before

Net income: $625M
Net income · +52% year on year · trailing twelve months to FY2025
Free cash flow: $599M
Free cash flow · trailing twelve months to FY2018
Operating margin: 13%
Operating margin · trailing twelve months to FY2025

Details›

Every series Ryufin has for SNN, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$6.16B	+6.1%	FY2025
Net income	$625M	+52%	FY2025
EPS	$0.72	+52%	FY2025
Gross margin	68%	n/a	FY2025
Operating margin	13%	n/a	FY2025
Net margin	10%	n/a	FY2025
ROE	12%	n/a	FY2025
ROA	6.0%	n/a	FY2025
ROIC	7.9%	n/a	FY2025
Free cash flow	$599M	n/a	FY2018
P/E	38.0	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.